265 related articles for article (PubMed ID: 26185130)
1. Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.
Leone P; Berardi S; Frassanito MA; Ria R; De Re V; Cicco S; Battaglia S; Ditonno P; Dammacco F; Vacca A; Racanelli V
Blood; 2015 Sep; 126(12):1443-51. PubMed ID: 26185130
[TBL] [Abstract][Full Text] [Related]
2. Myeloma escape from immunity: an "inside" job.
Rapoport AP
Blood; 2015 Sep; 126(12):1401-3. PubMed ID: 26384282
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma.
Racanelli V; Leone P; Frassanito MA; Brunetti C; Perosa F; Ferrone S; Dammacco F
Blood; 2010 Feb; 115(6):1185-93. PubMed ID: 20008301
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma.
Dhodapkar KM; Barbuto S; Matthews P; Kukreja A; Mazumder A; Vesole D; Jagannath S; Dhodapkar MV
Blood; 2008 Oct; 112(7):2878-85. PubMed ID: 18669891
[TBL] [Abstract][Full Text] [Related]
5. Bone-marrow plasmocytosis--an immunohistological study.
Eckert F; Schmid L; Kradolfer D; Schmid U
Blut; 1986 Jul; 53(1):11-9. PubMed ID: 3719110
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.
Pessoa de Magalhães RJ; Vidriales MB; Paiva B; Fernandez-Gimenez C; García-Sanz R; Mateos MV; Gutierrez NC; Lecrevisse Q; Blanco JF; Hernández J; de las Heras N; Martinez-Lopez J; Roig M; Costa ES; Ocio EM; Perez-Andres M; Maiolino A; Nucci M; De La Rubia J; Lahuerta JJ; San-Miguel JF; Orfao A; ;
Haematologica; 2013 Jan; 98(1):79-86. PubMed ID: 22773604
[TBL] [Abstract][Full Text] [Related]
7. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
[TBL] [Abstract][Full Text] [Related]
8. Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy.
Bailur JK; McCachren SS; Doxie DB; Shrestha M; Pendleton K; Nooka AK; Neparidze N; Parker TL; Bar N; Kaufman JL; Hofmeister CC; Boise LH; Lonial S; Kemp ML; Dhodapkar KM; Dhodapkar MV
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31013254
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.
Bi E; Li R; Bover LC; Li H; Su P; Ma X; Huang C; Wang Q; Liu L; Yang M; Lin Z; Qian J; Fu W; Liu YJ; Yi Q
J Clin Invest; 2018 Nov; 128(11):4821-4831. PubMed ID: 30277474
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?
Tucci M; Stucci S; Strippoli S; Dammacco F; Silvestris F
Oncologist; 2011; 16(7):1040-8. PubMed ID: 21659611
[TBL] [Abstract][Full Text] [Related]
11. Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.
Goodyear OC; Pratt G; McLarnon A; Cook M; Piper K; Moss P
Blood; 2008 Oct; 112(8):3362-72. PubMed ID: 18658027
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro.
Jung SH; Lee YK; Lee HJ; Choi NR; Vo MC; Hoang MD; Lim MS; Nguyen-Pham TN; Kim HJ; Lee JJ
Exp Hematol; 2014 Apr; 42(4):274-81. PubMed ID: 24407159
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-based therapeutic vaccination against myeloma: vaccine formulation determines efficacy against light chain myeloma.
Cohen S; Haimovich J; Hollander N
J Immunol; 2009 Feb; 182(3):1667-73. PubMed ID: 19155516
[TBL] [Abstract][Full Text] [Related]
14. Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro.
Frassanito MA; Ruggieri S; Desantis V; Di Marzo L; Leone P; Racanelli V; Fumarulo R; Dammacco F; Vacca A
Eur J Haematol; 2015 Jul; 95(1):65-74. PubMed ID: 25409753
[TBL] [Abstract][Full Text] [Related]
15. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
[TBL] [Abstract][Full Text] [Related]
16. Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
Hundemer M; Schmidt S; Condomines M; Lupu A; Hose D; Moos M; Cremer F; Kleist C; Terness P; Belle S; Ho AD; Goldschmidt H; Klein B; Christensen O
Exp Hematol; 2006 Apr; 34(4):486-96. PubMed ID: 16569595
[TBL] [Abstract][Full Text] [Related]
17. Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis?
Mongkonsritragoon W; Kimlinger T; Ahmann G; Greipp PR
Leuk Lymphoma; 1998 May; 29(5-6):577-84. PubMed ID: 9643571
[TBL] [Abstract][Full Text] [Related]
18. Light chain restriction analysis of bone marrow plasma cells in patients with MGUS or 'solitary' plasmacytoma: diagnostic value and correlation with clinical course.
Bezwoda WR; Gordon V; Bagg A; Mendelow B
Br J Haematol; 1990 Apr; 74(4):420-3. PubMed ID: 2112025
[TBL] [Abstract][Full Text] [Related]
19. Multiple Myeloma and the Immune Microenvironment.
Kawano Y; Roccaro AM; Ghobrial IM; Azzi J
Curr Cancer Drug Targets; 2017; 17(9):806-818. PubMed ID: 28201978
[TBL] [Abstract][Full Text] [Related]
20. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
